Bipolar Disorder
1,146
84
106
777
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
260 trials with published results (23%)
Research Maturity
777 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.5%
86 terminated out of 1146 trials
90.0%
+3.5% vs benchmark
28%
317 trials in Phase 3/4
33%
260 of 777 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 777 completed trials
Clinical Trials (1146)
Early Intervention for Youth at High Risk for Bipolar Disorder
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Imaging mGluR5 and Synaptic Density in Psychiatric Disorders
Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
Evaluation of the Genetics of Bipolar Disorder
Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Effectiveness RCT of Customized Adherence Enhancement
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
Transcranial Electric Stimulation Therapy (TEST) for Treatment Resistant Depression (TRD)
Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder
Neuronavigation rTMS to Improve Depressive Episodes of Bipolar Disorder in Adolescent
Rochester Forensic Assertive Community Treatment Model in Minnesota
Predictors of Intravenous Ketamine Response in TRD
Personalized Mobile Cognitive Behavioral Therapy Application
Immuno-Genetic, Inflammation, Retro-Virus, Environment